Skip to content

HR 9077 · 119th Congress

To direct the Director of the National Institutes of Health and the Secretary of Health and Human Services to evaluate hormone variability and hormone testing, respectively, in women with respect to perimenopause.

Introduced May 29, 2026Last action May 29, 2026Congress.gov →

Latest action

Referred to the House Committee on Energy and Commerce.

Sponsor

Hillary J. ScholtenDemocrat · MI-3Profile →